ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 68 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $96 | +118.2% | 88,234 | +193.1% | 0.01% | +66.7% |
| Q4 2022 | $44 | -99.9% | 30,103 | -25.7% | 0.01% | +50.0% |
| Q3 2022 | $44,000 | +51.7% | 40,503 | +133.7% | 0.00% | +100.0% |
| Q2 2022 | $29,000 | -42.0% | 17,328 | -29.2% | 0.00% | -50.0% |
| Q1 2022 | $50,000 | -79.7% | 24,470 | -48.5% | 0.00% | -81.8% |
| Q3 2021 | $246,000 | +23.6% | 47,542 | +139.6% | 0.02% | -4.3% |
| Q2 2020 | $199,000 | -50.7% | 19,845 | -67.2% | 0.02% | +9.5% |
| Q4 2017 | $404,000 | +75.7% | 60,473 | +115.6% | 0.02% | +90.9% |
| Q3 2017 | $230,000 | – | 28,051 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $1,501,250 | 2.44% |
| NEA Management Company, LLC | 17,079,779 | $18,616,958 | 1.29% |
| Endurant Capital Management LP | 1,660,835 | $1,810,310 | 0.93% |
| Matrix Capital Management Company, LP | 38,974,185 | $42,481,862 | 0.58% |
| Long Focus Capital Management, LLC | 5,435,439 | $5,924,629 | 0.34% |
| PFM Health Sciences, LP | 5,992,571 | $6,531,902 | 0.29% |
| Key Client Fiduciary Advisors, LLC | 321,155 | $350,059 | 0.22% |
| DAFNA Capital Management LLC | 351,064 | $382,660 | 0.12% |
| Rock Springs Capital Management LP | 2,787,845 | $3,038,751 | 0.07% |
| Baker Brothers Advisors | 9,830,877 | $10,715,656 | 0.06% |